Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic ModelLauren E. Abrey, Lisa M. DeAngelis, Christopher J. Schultz et al.|Journal of Clinical Oncology|2006Cited by 620
Central pathology review in clinical trials for patients with malignant glioma. A report of radiation therapy oncology group 83-02Charles Scott, Diana F. Nelson, James S. Nelson et al.|Cancer|1995Cited by 89
Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: A report of radiation therapy oncology group (RTOG) 83-02Kevin Murray, Walter J. Curran, Nancy Farnan et al.|International Journal of Radiation Oncology*Biology*Physics|1995Cited by 60